TP53 and cancer: Two of the most recurrent cytogenetic abnormalities observed among different types of cancers were gain of chromosome 8q (encoding the MYC oncogene) and loss of 17p (encoding the TP53 tumor suppressor gene) [60], suggesting that aneuploidy could underlie transformation by amplification of oncogenes or loss of tumor suppressors (Fig. 1).